Multi-Tasking or Focus?

Share this story on:

Share on facebook
Share on google
Share on twitter
Share on linkedin

“Given the importance of focus, it’s disheartening to find that like most of us, many of today’s business leaders and CEOs have fallen victim to the myth of multitasking: The more jobs they take on, the more goals they set, the more meetings they attend, the more chances they will have to succeed. Instead, the C-suite’s infatuation with multitasking has brought senior executives to the point where when they are able to focus, they focus on the wrong things, addressing only the latest-and-loudest item in the inbox instead of something strategic and long-range.

“In a study from the University of California-Irvine, researchers analyzed business productivity. Here’s what study lead Gloria Mark told Fast Company about on-the-job interruptions: “When you have to completely shift your thinking, it takes time to move into the new area of focus, then more time to get back to what you were originally working on.  We found about 82 percent of all interrupted work is resumed on the same day. But here’s the bad news: It takes an average of 23 minutes and 15 seconds to get back to the original task.” Source: Trey Taylo, BenefitsPro

Recent Posts

Teresa

Workplace Injuries Cost

“Workplace injuries cost US companies more than $1 billion per week, according to new data from Liberty Mutual. “According to Liberty Mutual, the 10 costliest

Read More »
Teresa

FDA: Reports of Seizures

“The Food and Drug Administration is investigating dozens of reports of people who experienced seizures after using e-cigarettes. “The agency announced Wednesday that it has

Read More »
Teresa

Centene Buying WellCare

“Centene Corp. has said it will buy fellow Medicaid insurer WellCare Health Plans in an estimated $17.3 billion deal. “All in all, the two insurers

Read More »
Teresa

Acting FDA Commissioner

It has been announced that Ned Sharpless, the director of the National Cancer Institute, will be named the acting commissioner of the Food and Drug

Read More »
Teresa

FDA’s Gottleib Resigns

“Scott Gottlieb, MD, announced his resignation as chief of the FDA on March 5. He plans to leave his post sometime next month. “Dr. Gottlieb

Read More »

copyright © 2019